Back

Combined effects of lipoprotein(a) and HDL cholesterol on cardiovascular mortality: a longitudinal study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Lipoprotein(a) (1) Lipids ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Byung Jin Kim

Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
High lipoprotein(a) and high BMI jointly confer the highest risk of ASCVD in both primary and secondary prevention
Mr P. Thomas (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Extra-virgin olive oil intake and lipoprotein A levels in the PREDIMED-Plus study
Doctor J. Diaz-Gutierrez (Huelva, ES)
Abstract Slides Video
Presentation thumbnail
Lipoprotein(a), high-sensitive c reactive protein, and long-term survival after coronary artery bypass grafting
Doctor S. Yuan (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Patient views on lipoprotein (a) testing and treatment for secondary prevention of cardiovascular disease - results from 7 countries across 6 WHO regions from the INTERASPIRE study
Professor C. Jennings (Galway, IE)
Abstract Slides
Presentation thumbnail
Impact of lipoprotein(a) concentrations on atherosclerotic cardiovascular disease onset: a survival analysis
Doctor V. Zorzanelli Rocha (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Lipoprotein(a) (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) and cardiovascular prognosis of familial dyslipidemias: data from a 10-year follow-up study
thumbnail
Congress Presentation
Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: design, rationale, and first results of the Zabrze-Lip(a)R Registry
thumbnail
Congress Presentation
Lipoprotein(a), high-sensitive c reactive protein, and long-term survival after coronary artery bypass grafting

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources